Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC)
BeOne Medicines
BeOne Medicines
BeOne Medicines
Indaptus Therapeutics, Inc
HiFiBiO Therapeutics
HiFiBiO Therapeutics
Sun Yat-sen University
BeiGene
Sun Yat-sen University
Akeso
Chipscreen Biosciences, Ltd.